<

ACHIKO AG EQS-Adhoc: Achiko completes share capital increase

Transparency directive : regulatory news

14/12/2021 18:30

EQS-Ad-hoc: Achiko AG / Key word(s): Miscellaneous
Achiko completes share capital increase

14-Dec-2021 / 18:30 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.


Achiko completes share capital increase

Zurich, 14 December 2021: Ad hoc announcement pursuant to Art. 53 LR - Achiko AG (SWX: ACHI, ISIN CH0522213468) announces that its share capital recorded in the commercial register has been increased by 10,081,666 shares to 118,985,566 shares to satisfy claims from a share lending relied on in connection with a private placement. The new shares have been issued out of the existing authorized capital.

ABOUT ACHIKO AG
Achiko creates and develops new innovations in healthcare technology through its biotechnology division, AptameXTM, and its sister digital mobile health technology division, Teman SehatTM. The Company has created a unique healthtech capability that provides user-friendly diagnostic testing integrated with a digital passport solution for the management of Covid-19.

AptameX comprises of DNA aptamer-based technology that is cost-effective, chemically synthesised and widely applicable to the evolving diagnostic field of healthcare. Together with the digital mobile health app Teman Sehat, Achiko is developing potential technologies that seek to deliver rapid, affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications. The AptameX technology is licensed from Regenacellx.sl and Achiko has exclusive commercialisation rights.

Headquartered in Zurich, Achiko has offices in Hong Kong, Jakarta, Seoul and Singapore.

Further information can be found at www.achiko.com.

Media contacts:

ACHIKO AG
Investor Relations
E: ir@achiko.com

Switzerland & Global
Marcus Balogh
Farner Consulting Ltd.
E: achiko@farner.ch
T: +41 44 266 67 67


U.S. & Global
Jeanene Timberlake
RooneyPartners
E: jtimberlake@rooneypartners.com
T: +1 646 770 8858

Disclaimer
This communication expressly or implicitly contains certain forward-looking statements concerning Achiko AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of Achiko AG to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Achiko AG is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.



End of ad hoc announcement
Language: English
Company: Achiko AG
Tessinerplatz 7
8002 Zurich
Switzerland
E-mail: ir@achiko.com
Internet: https://www.achiko.com/
ISIN: CH0522213468
Valor: 48788430
Listed: SIX Swiss Exchange
EQS News ID: 1257797

 
End of Announcement EQS News Service

1257797  14-Dec-2021 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1257797&application_name=news&site_id=symex

ACHIKO AG's latest news



Other stories

28/03/2024 20:19
28/03/2024 23:45
28/03/2024 16:58
28/03/2024 16:56
28/03/2024 18:06
29/03/2024 00:02
28/03/2024 21:42
28/03/2024 22:37
28/03/2024 22:17
28/03/2024 20:49
28/03/2024 19:33
28/03/2024 22:03
28/03/2024 22:21
28/03/2024 21:27
29/03/2024 00:59
28/03/2024 23:13
28/03/2024 17:01
28/03/2024 09:59
27/03/2024 15:52
27/03/2024 17:52
27/03/2024 17:30
28/03/2024 09:00
28/03/2024 21:31
28/03/2024 19:00
28/03/2024 18:05
28/03/2024 17:45
29/03/2024 00:37
29/03/2024 00:17
28/03/2024 13:34
28/03/2024 17:34
27/03/2024 15:13
27/03/2024 21:46
27/03/2024 13:40
28/03/2024 17:23
29/03/2024 00:01
28/03/2024 17:47
28/03/2024 13:25
28/03/2024 11:40